|
|
|
|
|
|
|
M Tue W Th F |
|
9 June, 2026 |
|
|
sponsored by
|
|
|
|
Secure Your Commercial Supply
|
| To support your commercial success, we're expanding our large-scale biologics drug product manufacturing capabilities, providing end-to-end solutions through our global network and enabling seamless integration of drug substance and drug product. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
That sound you hear is the drug industry breathing the slightest sigh of relief. Top Republican senate appropriators signaled at a hearing today that there is no appetite for a third reconciliation bill later this year. Whispers among industry sources suggested that may have been an avenue for the administration's push to codify 'most favored nation' deals agreed to last year.
Of course, nothing is ever really dead on Capitol Hill. But as near-term policy fights shift to China deals, the latest reconciliation update is, at least for now, welcome news for pharma. |
|
|
|
Max Bayer |
Senior Reporter, Endpoints News
|
|
|
|
|
|
|
by Zachary Brennan
|
Grace Science appeared to be one of the few companies fighting ultra-rare diseases whose gene therapy candidate might make it across the finish line. Co-founded... | |
|
|
|
|
|
|
by Nicole DeFeudis
|
Eli Lilly’s deadline has passed for hospitals to comply with its new 340B claims data policy, and for now the pharma company is staying mum... | |
|
|
|
|
|
|
|
|
by Anna Brown
|
Another wave of scrutiny has hit WuXi AppTec through its re-inclusion in the Pentagon’s updated list of companies that have ties to the Chinese military... | |
|
|
|
 |
|
|
|
by Andrew Dunn
|
The one law of CEO pay packages: They keep getting bigger. Yesterday, we published the first installment of Endpoints News’ annual biopharma compensation project. Following... | |
|
|
|
 |
|
|
|
by Andrew Dunn
|
The typical worker in biopharma made $116,648 in 2025, according to an Endpoints News pay analysis, earning about 30% more than the typical employee of... | |
|
|
|
